Scribd
Upload
822 views1 page

Omkar Misra Blood Cancer

The final report for patient Omkar Misra indicates a high likelihood of blood cancer based on tumor marker levels, despite the presence of chronic liver disease and renal failure. The report suggests a diagnosis of malignant neoplasm of blood (ICD-10-CM code C50) and emphasizes that the algorithm used has a sensitivity of 82.3% and specificity of 85.7%. It is intended for use by healthcare professionals as a clinical decision support system, not as a sole diagnostic tool.

Uploaded by

omkartatacapital
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
822 views1 page

Omkar Misra Blood Cancer

The final report for patient Omkar Misra indicates a high likelihood of blood cancer based on tumor marker levels, despite the presence of chronic liver disease and renal failure. The report suggests a diagnosis of malignant neoplasm of blood (ICD-10-CM code C50) and emphasizes that the algorithm used has a sensitivity of 82.3% and specificity of 85.7%. It is intended for use by healthcare professionals as a clinical decision support system, not as a sole diagnostic tool.

Uploaded by

omkartatacapital
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 1

000058755460

BLOOD CANCER OXR – FINAL REPORTOncoBREAST Dx

Patient Information

Identification Data General Biochemistry Blood Drawn Realization


HRN: BRE00000273 Creatinine (mg/dL): 1.00 Blood Drawn Date: 25-01-2025
Name: OMKAR MISRA ASAT (U/L): 8.00
ALAT (U/L): 12.00 Urine Tumor Markers
Personal Data GGT (U/L): 7.00 8-OHdG (ng/mL): 11.10
Age (years): 28 Total Bilirubin (mg/dL): 1.00
Hemolized Sample: No Urine Drawn Realization
Comorbidities Urine Drawn Date: 25-01-2020
Atherosclerosis: No Serum Tumor Markers
Chronic Liver Disease: Yes CA 15.3 (U/mL): 19.70 Lifestyle
Diabetes Mellitus 1 or 2: No CEA (ng/mL): 1.60 Smoking: Positive
Jaundice: No EGFR (ng/mL): 5.00 Drinking: Positive
Renal Failure: Yes NGAL (ng/mL): 4.60
NSE (ng/mL): 7.00

Outcome

Results

“High”
Range: Low, Moderate, High

Comments
In absence of comorbidities that are well-known source of False Positive (FP) in healthy patients by
increasing some Tumor Markers levels, whole Tumor Markers levels suggest malignancy.

Conclusions
WE SUGGEST BLOOD CANCER. THE 2016 ICD-10-CM DIAGNOSIS CODE IS C50 (MALIGNANT
NEOPLASM OF BLOOD).

This report has been generated from the data entered on 25-01-2025 10:55:02 UTC/GMT.

Disclaimer
This Multiple Biomarkers Disease Activity Algorithm (MBDAA) for Blood Cancer has been developed for the
exclusive use by healthcare professionals, and solely as a Clinical Decision Support System (CDSS), not
as an unique element for diagnosis. The algorithm bears a Sensitivity = 82.3%, Specificity = 85.7%. Please
note, negativity of the Tumor Markers does not exclude at 100% the possibility of a malignant epithelial
tumor.

The Royal London Hospital, Technical Responsible


London Lorena Lendinez
Website: https://www.bartshealth.nhs.uk/the-royal-london/ Chief Scientific Officer
Call Mile End, St Bartholomew's or The Royal London: 020 7377 7000 The Royal London Hospital

Powered by TCPDF (www.tcpdf.org)

You might also like